JP2019524884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524884A5 JP2019524884A5 JP2019529463A JP2019529463A JP2019524884A5 JP 2019524884 A5 JP2019524884 A5 JP 2019524884A5 JP 2019529463 A JP2019529463 A JP 2019529463A JP 2019529463 A JP2019529463 A JP 2019529463A JP 2019524884 A5 JP2019524884 A5 JP 2019524884A5
- Authority
- JP
- Japan
- Prior art keywords
- pla2r
- cells
- seq
- epitope
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022076451A JP7411718B2 (ja) | 2016-08-12 | 2022-05-06 | 自己免疫疾患の診断、予防、および／または治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662374382P | 2016-08-12 | 2016-08-12 | |
| US62/374,382 | 2016-08-12 | ||
| PCT/US2017/046626 WO2018031947A1 (en) | 2016-08-12 | 2017-08-11 | Diagnosis, prevention, and/or treatment of autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076451A Division JP7411718B2 (ja) | 2016-08-12 | 2022-05-06 | 自己免疫疾患の診断、予防、および／または治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524884A JP2019524884A (ja) | 2019-09-05 |
| JP2019524884A5 true JP2019524884A5 (enExample) | 2020-09-03 |
| JP7303107B2 JP7303107B2 (ja) | 2023-07-04 |
Family
ID=61163324
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529463A Active JP7303107B2 (ja) | 2016-08-12 | 2017-08-11 | 自己免疫疾患の診断、予防、および／または治療 |
| JP2022076451A Active JP7411718B2 (ja) | 2016-08-12 | 2022-05-06 | 自己免疫疾患の診断、予防、および／または治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076451A Active JP7411718B2 (ja) | 2016-08-12 | 2022-05-06 | 自己免疫疾患の診断、予防、および／または治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11266717B2 (enExample) |
| EP (2) | EP4644899A3 (enExample) |
| JP (2) | JP7303107B2 (enExample) |
| CN (1) | CN109891245B (enExample) |
| ES (1) | ES3014985T3 (enExample) |
| WO (1) | WO2018031947A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4644899A3 (en) * | 2016-08-12 | 2026-04-08 | Immunowork, LLC | Diagnosis, prevention, and/or treatment of autoimmune diseases |
| EP3813885A4 (en) * | 2018-05-02 | 2022-01-12 | The Trustees of The University of Pennsylvania | COMPOSITIONS AND METHODS OF PHOSPHOLIPASE-A2 RECEPTOR CHIMERA AUTOANTIBODY RECEPTOR T CELLS |
| US12203933B2 (en) | 2018-08-15 | 2025-01-21 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating membranous nephropathy |
| EP4010704A1 (en) | 2019-08-06 | 2022-06-15 | Euroimmun Medizinische Labordiagnostika AG | An improved autoantibody detection assay |
| EP4031676A4 (en) | 2019-09-19 | 2023-10-25 | Mayo Foundation for Medical Education and Research | Methods and materials for identifying and treating membranous nephropathy |
| US12590165B2 (en) | 2020-03-06 | 2026-03-31 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B |
| CN112111015B (zh) * | 2020-09-24 | 2021-12-07 | 苏州携创生物技术有限公司 | PLA2R、C1q、THSD7A融合蛋白及其构建方法、应用 |
| CN112557670A (zh) * | 2020-12-07 | 2021-03-26 | 东南大学 | 一种基于尿液外泌体pla2r检测imn的方法、试剂盒及其应用 |
| BR102021022687A2 (pt) | 2020-12-11 | 2022-06-28 | Euroimmun Medizinische Labordiagnostika Ag | Método e reagentes para diagnosticar nefropatia membranosa |
| EP4380963A4 (en) * | 2021-08-05 | 2025-06-04 | The Trustees of The University of Pennsylvania | Compositions and methods of chimeric autoantibody receptor cells expressing extended phospholipase a2 receptor fragments |
| CN114588881B (zh) * | 2022-03-07 | 2023-07-18 | 大连理工大学 | 免疫吸附剂及其制备方法 |
| EP4496815A1 (en) * | 2022-03-23 | 2025-01-29 | Bodhi Bio LLC | Compositions and methods for antigen-specific therapy |
| CN116082517B (zh) * | 2022-05-26 | 2025-08-22 | 成都地奥制药集团有限公司 | 融合蛋白及其用途 |
| WO2024147113A1 (en) * | 2023-01-05 | 2024-07-11 | Glycoera Ag | Glycoengineered polypeptides targeting anti-podocyte autoantibodies and uses thereof |
| CN115951047A (zh) * | 2023-02-10 | 2023-04-11 | 大连大学 | 自身免疫性水疱病PBMCs直接免疫荧光诊断试剂盒 |
| EP4709746A1 (en) * | 2023-05-08 | 2026-03-18 | Canopy Immuno-Therapeutics Ltd. | Ig-like fusion proteins for treating membranous nephropathy |
| WO2025259945A1 (en) * | 2024-06-13 | 2025-12-18 | Astero BioPharma LLC | Approaches for the selective depletion of pla2r-specific antibodies |
| WO2026096624A1 (en) * | 2024-10-31 | 2026-05-07 | Bodhi Bio Llc | Antigen-specific therapy for autoimmune diseases |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE78407T1 (de) | 1988-10-21 | 1992-08-15 | Akzo Nv | Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten. |
| JPH07278196A (ja) * | 1994-04-05 | 1995-10-24 | Shionogi & Co Ltd | ヒトｉ型ホスホリパーゼａ２レセプター |
| CA2417885A1 (en) | 2000-08-01 | 2002-02-07 | The University Of Kansas | Cell internalized peptide-drug conjugates |
| CA2629306A1 (en) * | 2005-11-23 | 2007-05-31 | Genentech, Inc. | Methods and compositions related to b cell assays |
| KR20100007809A (ko) * | 2008-07-14 | 2010-01-22 | 삼성전자주식회사 | 미세유동장치, 이를 이용한 시료분석방법 및 희석비율측정방법 |
| ES2535640T3 (es) * | 2008-07-18 | 2015-05-13 | Boston Medical Center Corporation | Diagnósticos para nefropatía membranosa |
| WO2012145112A2 (en) | 2011-04-18 | 2012-10-26 | Immunogen, Inc. | Novel maytansinoid derivatives with sulfoxide linker |
| EP3467509B1 (en) * | 2011-05-04 | 2025-11-26 | Cellular Technology, Ltd | Cns antigen-specific b cell, t cell and antibody assays and their uses in diagnosis and treatment of multiple sclerosis |
| EP2864482A4 (en) | 2012-06-21 | 2016-02-10 | Miragen Therapeutics Inc | OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN |
| WO2015004603A1 (en) | 2013-07-09 | 2015-01-15 | Institut National De La Sante Et De La Recherche Medicale | Anti-pla2r antibody and uses thereof |
| GB201410108D0 (en) | 2014-06-06 | 2014-07-23 | Univ Manchester | Peptides, and methods and apparatus utilising same |
| CN104849452A (zh) * | 2015-05-14 | 2015-08-19 | 深圳市伯劳特生物制品有限公司 | 一种pla2r抗体定量检测试纸条及制作、检测方法 |
| CN105510575A (zh) | 2015-12-04 | 2016-04-20 | 深圳市伯劳特生物制品有限公司 | 抗磷脂酶A2受体抗体IgG试剂盒及检测方法 |
| EP4644899A3 (en) * | 2016-08-12 | 2026-04-08 | Immunowork, LLC | Diagnosis, prevention, and/or treatment of autoimmune diseases |
-
2017
- 2017-08-11 EP EP25158624.4A patent/EP4644899A3/en active Pending
- 2017-08-11 EP EP17840379.6A patent/EP3497452B1/en active Active
- 2017-08-11 JP JP2019529463A patent/JP7303107B2/ja active Active
- 2017-08-11 CN CN201780062647.9A patent/CN109891245B/zh active Active
- 2017-08-11 US US16/324,870 patent/US11266717B2/en active Active
- 2017-08-11 WO PCT/US2017/046626 patent/WO2018031947A1/en not_active Ceased
- 2017-08-11 ES ES17840379T patent/ES3014985T3/es active Active
-
2022
- 2022-03-07 US US17/688,811 patent/US20220193188A1/en active Pending
- 2022-05-06 JP JP2022076451A patent/JP7411718B2/ja active Active
-
2024
- 2024-04-10 US US18/631,559 patent/US20240252590A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017313138B2 (en) | A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay | |
| Mohankumar et al. | Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer | |
| JP2014239695A5 (enExample) | ||
| JP2014144959A5 (enExample) | ||
| JP2016507233A5 (enExample) | ||
| US10895572B2 (en) | Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients | |
| JP2017099394A (ja) | ヘッジホッグ阻害剤療法のためのバイオマーカー | |
| JP2017503488A5 (enExample) | ||
| CN107541563B (zh) | 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用 | |
| JP2016509833A5 (enExample) | ||
| AU2025238057A1 (en) | Methods for prostate cancer detection and treatment | |
| JP2015523569A5 (enExample) | ||
| JP2015504299A5 (enExample) | ||
| ES2721539T3 (es) | Materiales y métodos para pronóstico de evolución de esófago de Barrett | |
| RU2013113314A (ru) | Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками | |
| JP2018527886A5 (enExample) | ||
| Wang et al. | Establishment of a quantitative polymerase chain reaction assay for monitoring chimeric antigen receptor T cells in peripheral blood | |
| KR20160134817A (ko) | 암 치료 | |
| Liu et al. | Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study | |
| JP2017516501A (ja) | 肺がんのタイピング法 | |
| CN109022584B (zh) | 一种食管癌的分子标志物及其用途 | |
| Fukumoto et al. | Big endothelin-1 as a tumour marker for canine haemangiosarcoma | |
| Li et al. | Recent developments in affinity-based selection of aptamers for binding disease-related protein targets | |
| CN106755351B (zh) | 肝癌早期诊断试剂或试剂盒及用途 | |
| CN104962657B (zh) | Yap1基因在阿尔茨海默病诊治中的应用 |